Full Year Revenue Growth
Full year 2024 revenue saw an increase of 3% compared to 2023.
Operating Income and EPS Growth
Operating income for full year 2024 was up 7% and earnings per share was up 9% compared to 2023.
Debt Reduction
Core's net debt was reduced by nearly $12 million in Q4, lowering the leverage ratio to 1.31, the lowest in eight years.
Share Repurchase
Core Lab repurchased nearly 265,000 shares of company stock during the fourth quarter.
Increase in International Product Sales
International product sales increased by 8% year-over-year.
Completion Diagnostic Services Demand Increase
Demand for completion diagnostics increased, with growth in the Gulf of Mexico and international markets.
Free Cash Flow Improvement
Free cash flow for full year 2024 was $43.4 million, a significant improvement from $14.2 million in 2023.